Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 MAY 25 ... been named chief financial officer (CFO).
Borkowski, 49, has been CFO of Mylan, Inc. since 2002 where he helped transform the company from a U.S.-based generic ... Generics in 2007. Borkowski also played a key role in Mylan's acquisition of Matrix Laboratories in 2006, the largest acquisition in India's pharmaceutical sector at the time. He ...
2009 JUN 1 ... Penederm, a publicly traded drug delivery company acquired by Pittsburgh, PA-based MylanLaboratories in 1998.
Mr. Malchow has also held executive positions at ... businesses. From 1999 to 2007 he worked for San Diego-based LMA North America, Inc., and was most recently its President and Chief Executive Officer. LMA, a publicly ...
2009 AUG 31 ... Therefore, the recall pertains to Digitek tablets (all strengths) distributed by Mylan Pharmaceuticals and sold under the label "Bertek", as well as Digitek distributed by ... and sold under the label "Bertek", as well as Digitek distributed by UDL Laboratories, Inc. and sold under the label "UDL". Keywords: Eichen Levinson & ...
2009 MAY 4 ... Center for CNS Research. Earlier in his career, Dr. Bobotas has held senior positions at MylanLaboratories, Somerset Pharmaceuticals and Forest Laboratories. He is the inventor of 24 ...
2009 MAY 19 ... MylanInc. (NASDAQ:MYL) announced a change in leadership to its Board of Directors. Mylan ... in the world with the 2007 game-changing acquisitions of a majority interest in Matrix Laboratories and the global generics business of Merck KGaA. Prior to joining Mylan, Coury was the ...
2009 AUG 10 ... MylanInc. (NASDAQ:MYL) announced several key enhancements to its executive management team. ... most recently as executive vice president, Global Generic Sales and Marketing, for Barr Laboratories, whose parent company, Barr Pharmaceuticals, was acquired by Teva. In that position, ...
2009 NOV 1 ... MylanInc. (NASDAQ:MYL) announced that the company's Mylan Pharmaceuticals and Matrix ... Mylan Inc. (NASDAQ:MYL) announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating ...
2009 NOV 23 ... MylanInc. (NASDAQ:MYL) announced that its privately held Indian subsidiary, Matrix ... Mylan Inc. (NASDAQ:MYL) announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S. Food and Drug Administration (FDA) ...
2009 NOV 2 ... MylanInc. (NASDAQ:MYL) announced that two of its subsidiaries have resolved a longstanding ... rebate classifications. Mylan's subsidiaries Mylan Pharmaceuticals Inc. and UDL Laboratories Inc. settled civil claims first brought to Mylan's attention in 2005. The settlement of ...
2009 SEP 28 ... MylanInc. (NASDAQ:MYL) announced that its privately held Indian subsidiary, Matrix ... Mylan Inc. (NASDAQ:MYL) announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration ...
2009 AUG 3 ... Merck & Co. Inc. Merck Serono International S.A. Mylan, Inc. Novartis AG Pfizer, Inc. Ranbaxy ... 292 companies including many key and niche players worldwide such as Abbott Laboratories Allergan, Inc. Amgen, Inc. AstraZeneca ...
2009 AUG 17 ... President Bill Clinton, Mylan Chairman and CEO Robert J. Coury and Matrix Laboratories Founder and Vice Chairman N. ... annually. Addressing the need for more affordable second-line ARVs, Mylan Inc. (NASDAQ:MYL) and Matrix, a Mylan company, are making available all four drugs -- ...
